We recently came across a slew of items on drug retailing giant CVS Caremark.  A number of observers have noted that the company looks undervalued, especially on a sum-of-the-parts basis.  Fortunately for the longs there seems to be a catalyst on the horizon.  A worsening flu season could lead to higher foot traffic (and sales) at their stores.  In addition the company’s stock has been underperforming its closest peer Walgreens since the middle of 2010.  In today’s screencast we take a look at the chatter surrounding CVS stock.

Items mentioned in the above screencast:

35 undervalued stocks trading under $35.  (Value Expectations)

The case for CVS Caremark being undervalued.  (SumZero)

@CapitalObserver, “New position in drugstore chain $CVS . Remarkably steady business, that has little economic sensitivity for a below market multiple.” (StockTwits)

Drugstore traffic up due to worse than expected flu season.  (Business Insider)

@suriNotes, a bullish pattern in CVS.  (Chart.ly)

Daily price chart of CVS Caremark (CVS).  (Finviz)

Price ratio chart of CVS vs. Walgreens (WAG).  (StockCharts)

*No position in CVS.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.